Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UBX
3201
DELISTED
Unity Biotechnology
UBX
| $138K | ﹤0.01% |
93,670
+29,088
| +45% | +$42.7K |
|
3202
US Gold Corp
USAU
$249M
| $138K | ﹤0.01% |
23,686
+12,635
| +114% | +$70.8K |
|
3203
Rafael Holdings
RFL
$107M
| $137K | ﹤0.01% |
71,517
+4,299
| +6% | +$6.44K |
|
3204
GEN Restaurant Group
GENK
$10.9M
| $137K | ﹤0.01% |
16,200
-18,999
| -54% | -$161K |
|
|
HOOK
3205
DELISTED
HOOKIPA Pharma
HOOK
| $135K | ﹤0.01% |
31,470
+1,245
| +4% | +$6.58K |
|
3206
Perimeter Solutions
PRM
$5.71B
| $135K | ﹤0.01% |
+10,000
| New | +$104K |
|
|
AXG
3207
Solowin Holdings
AXG
$535M
| $134K | ﹤0.01% |
45,900
+4,600
| +11% | +$12.9K |
|
3208
Alset
AEI
$42M
| $132K | ﹤0.01% |
102,666
+1,400
| +1% | +$1.62K |
|
|
CBIO
3209
Crescent Biopharma
CBIO
$587M
| $132K | ﹤0.01% |
7,811
-458
| -6% | -$9.61K |
|
3210
POET Technologies
POET
$1.44B
| $132K | ﹤0.01% |
+29,640
| New | +$92.5K |
|
3211
ReWalk Robotics
LFWD
$20.4M
| $130K | ﹤0.01% |
3,334
+42
| +1% | +$1.8K |
|
|
WBTN
3212
WEBTOON Entertainment Inc
WBTN
$1.27B
| $130K | ﹤0.01% |
+11,400
| New | +$181K |
|
3213
Context Therapeutics
CNTX
$57.2M
| $129K | ﹤0.01% |
66,000
+800
| +1% | +$1.77K |
|
|
FTH
3214
Faeth Therapeutics
FTH
$666M
| $129K | ﹤0.01% |
10,779
-410
| -4% | -$5K |
|
3215
Daxor
DXR
$61.2M
| $128K | ﹤0.01% |
14,821
-300
| -2% | -$2.68K |
|
3216
Sono-Tek
SOTK
$85.2M
| $127K | ﹤0.01% |
31,500
+700
| +2% | +$2.83K |
|
|
LGO
3217
Largo
LGO
$70.6M
| $127K | ﹤0.01% |
60,697
+16,797
| +38% | +$31.3K |
|
3218
Aura Biosciences
AURA
$732M
| $127K | ﹤0.01% |
14,200
-57,900
| -80% | -$496K |
|
3219
Enlivex Ltd
ENLV
$37M
| $126K | ﹤0.01% |
4,986
+207
| +4% | +$4.21K |
|
3220
TETRA Technologies
TTI
$1.26B
| $126K | ﹤0.01% |
40,500
+14,300
| +55% | +$46.1K |
|
3221
Broadway Financial
BYFC
$99.2M
| $124K | ﹤0.01% |
19,249
+5,200
| +37% | +$31K |
|
3222
ESS Tech
GWH
$21.6M
| $124K | ﹤0.01% |
19,560
+6,013
| +44% | +$54.5K |
|
|
SOHO
3223
DELISTED
Sotherly Hotels
SOHO
| $123K | ﹤0.01% |
101,914
+20,500
| +25% | +$25.2K |
|
3224
Vroom Inc
VRM
$47.5M
| $123K | ﹤0.01% |
13,126
| – | – |
|
3225
KALA BIO
KALA
$14M
| $122K | ﹤0.01% |
+429
| New | +$135K |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.